Catalyst Wire Dossier Catalyst Wire Dossier

DESyne BDS Plus Drug Eluting Coronary Stent System

drug-eluting coronary stent system · Elixir Medical Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DESyne BDS Plus Drug Eluting Coronary Stent System, covering 2024-08-27 to 2024-08-27. Get the full timeline:

Most recent: Clinical Trial Update: The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions [Phase 2]

See pricing